These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 8385959

  • 1. Proliferation and Na+/H+ antiport activity in human fibroblasts from type I diabetic patients with nephropathy.
    Soussan K, Dausse E, Hannedouche T, Timsit J, Lemoult F, Boitard C, Grünfeld JP, Guicheney P.
    Am J Hypertens; 1993 Feb; 6(2):170-3. PubMed ID: 8385959
    [Abstract] [Full Text] [Related]

  • 2. Na+/H+ antiport activity and cell growth in cultured skin fibroblasts of IDDM patients with nephropathy.
    Trevisan R, Li LK, Messent J, Tariq T, Earle K, Walker JD, Viberti G.
    Diabetes; 1992 Oct; 41(10):1239-46. PubMed ID: 1327925
    [Abstract] [Full Text] [Related]

  • 3. Growth phenotype of cultured skin fibroblasts from IDDM patients with and without nephropathy and overactivity of the Na+/H+ antiporter.
    Lurbe A, Fioretto P, Mauer M, LaPointe MS, Batlle D.
    Kidney Int; 1996 Nov; 50(5):1684-93. PubMed ID: 8914037
    [Abstract] [Full Text] [Related]

  • 4. Intracellular pH and Na+/H+ antiport activity of cultured skin fibroblasts from diabetics.
    Davies JE, Ng LL, Kofoed-Enevoldsen A, Li LK, Earle KA, Trevisan R, Viberti G.
    Kidney Int; 1992 Nov; 42(5):1184-90. PubMed ID: 1333551
    [Abstract] [Full Text] [Related]

  • 5. Leucocyte Na+/H+ antiport activity in type 1 (insulin-dependent) diabetic patients with nephropathy.
    Ng LL, Simmons D, Frighi V, Garrido MC, Bomford J, Hockaday TD.
    Diabetologia; 1990 Jun; 33(6):371-7. PubMed ID: 2165946
    [Abstract] [Full Text] [Related]

  • 6. Abnormal Na+/H+ antiport activity in cultured fibroblasts from NIDDM patients with hypertension and microalbuminuria.
    Trevisan R, Cipollina MR, Duner E, Trevisan M, Nosadini R.
    Diabetologia; 1996 Jun; 39(6):717-24. PubMed ID: 8781768
    [Abstract] [Full Text] [Related]

  • 7. Insulin-dependent diabetic sibling pairs are concordant for sodium-hydrogen antiport activity.
    Trevisan R, Fioretto P, Barbosa J, Mauer M.
    Kidney Int; 1999 Jun; 55(6):2383-9. PubMed ID: 10354286
    [Abstract] [Full Text] [Related]

  • 8. Integrated analysis of erythrocyte Na+/H+ antiport activity and left ventricular myocardial function in type I insulin-dependent diabetes mellitus.
    Matteucci E, Di Bello V, Giampietro O.
    J Diabetes Complications; 1995 Jun; 9(4):208-11. PubMed ID: 8573728
    [Abstract] [Full Text] [Related]

  • 9. Platelet Na+/H+ antiport activity in patients with insulin-dependent diabetes mellitus with and without diabetic nephropathy.
    Düsing R, Sorger M, Mattes L, Göbel BO, Hoffmann G, Rosskopf D, Vetter H, Siffert W.
    Clin Investig; 1993 Feb; 71(2):119-25. PubMed ID: 8384910
    [Abstract] [Full Text] [Related]

  • 10. Effect of protein kinase C modulators on the leucocyte Na+/H+ antiport in type 1 (insulin-dependent) diabetic subjects with albuminuria.
    Ng LL, Simmons D, Frighi V, Garrido MC, Bomford J.
    Diabetologia; 1990 May; 33(5):278-84. PubMed ID: 2165458
    [Abstract] [Full Text] [Related]

  • 11. Erythrocyte Na+/H+ exchange and preclinical abnormalities of the left ventricular diastolic function in normotensive type 1 (insulin-dependent) diabetic patients.
    Giampietro O, Di Bello V, Matteucci E, Talarico L, Ruberti F, Boldrini E, Giorgi D, Giusti C.
    Acta Diabetol; 1997 Oct; 34(3):223-9. PubMed ID: 9401645
    [Abstract] [Full Text] [Related]

  • 12. Activation of the Na+/H+ antiport is not required for epidermal growth factor-dependent gene expression, growth inhibition or proliferation in human breast cancer cells.
    Church JG, Mills GB, Buick RN.
    Biochem J; 1989 Jan 01; 257(1):151-7. PubMed ID: 2537620
    [Abstract] [Full Text] [Related]

  • 13. Simvastatin and intracellular pH regulation by the Na+/H+ antiport of SV40-virus-transformed human MRC5 fibroblasts.
    Davies JE, Ng LL.
    Clin Sci (Lond); 1993 Jun 01; 84(6):633-43. PubMed ID: 8392920
    [Abstract] [Full Text] [Related]

  • 14. Lipids and cellular Na+/H+ antiport activity in diabetic nephropathy.
    Ng LL, Davies JE.
    Kidney Int; 1992 Apr 01; 41(4):872-6. PubMed ID: 1325009
    [Abstract] [Full Text] [Related]

  • 15. Temporal profile of serum-induced S-phase entry and retinoblastoma protein phosphorylation in human skin fibroblasts.
    Danesh FR, Ye M, Salmi S, Lapointe M, Batlle D.
    Kidney Int; 1999 Oct 01; 56(4):1282-5. PubMed ID: 10504475
    [Abstract] [Full Text] [Related]

  • 16. Pathophysiology of renal and vascular disorders in insulin-dependent diabetes.
    Viberti G.
    Am J Hypertens; 1993 Apr 01; 6(4):135S-139S. PubMed ID: 8389562
    [Abstract] [Full Text] [Related]

  • 17. Na+/H+ exchanger isoform-1 abundance in skin fibroblasts of type I diabetic patients with nephropathy.
    Siczkowski M, Davies JE, Sweeney FP, Kofoed-Enevoldsen A, Ng LL.
    Metabolism; 1995 Jun 01; 44(6):791-5. PubMed ID: 7783665
    [Abstract] [Full Text] [Related]

  • 18. A specific mutation abolishing Na+/H+ antiport activity in hamster fibroblasts precludes growth at neutral and acidic pH.
    Pouysségur J, Sardet C, Franchi A, L'Allemain G, Paris S.
    Proc Natl Acad Sci U S A; 1984 Aug 01; 81(15):4833-7. PubMed ID: 6087349
    [Abstract] [Full Text] [Related]

  • 19. Cultured skin fibroblasts as an in vitro model to assess phenotypic features in subjects with diabetic nephropathy.
    LaPointe MS, Batlle D.
    Am J Kidney Dis; 2001 Sep 01; 38(3):646-8. PubMed ID: 11532699
    [No Abstract] [Full Text] [Related]

  • 20. Risk factors for renal and cardiovascular disease in diabetic patients.
    Viberti GC, Messent J.
    Cardiology; 1991 Sep 01; 79 Suppl 1():55-61. PubMed ID: 1655264
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.